Mr. Hariharan Thirumalai Vengateswaran | Nanotechnology | Young Scientist Award
Dr at B. S. Abdur Rahman Crescent Institute of Science and Technology, India
Hariharan Thirumalaivengateswaran is an aspiring pharmacist with a strong academic record at B. S. Abdur Rahman Crescent Institute of Science and Technology, expected to graduate in March 2025 with a remarkable CGPA of 9.71. Specializing in nanoparticle synthesis and pharmaceutical R&D, Hariharan has excelled in scientific writing and communication, presenting research at international conferences and publishing in prestigious journals. With hands-on experience in nanocomposite development and computational techniques, he aims to advance biomedical sciences through innovative research. Hariharan also actively participates in workshops and webinars, demonstrating a commitment to continuous learning and professional development in pharmacy.
profile:
š§Ŗ Expertise
Nanoparticle synthesis, Scientific writing and publication, Pharmaceutical research and development, Strong written and oral communication skills
š Education
Bachelor of Pharmacy B. S. Abdur Rahman Crescent Institute of Science and Technology, Vandalur, Tamil Nadu 2021 – 2025 (Expected Graduation: March 2025) CGPA: 9.71/10 (till 5th semester). Higher Secondary Education Kendriya Vidyalaya Sangathan no.2, Mangaluru, Karnataka 2020 – 2021 Graduated: April 2021 CGPA: 80%
š¬ Research
Development and characterization of carboxylated copper oxide conjugated polymeric nanocomposites and correlating with computational techniques Mentor: Dr. Mohammad Habeeb Institution: SRM Institute of Science and Technology, B. S. Abdur Rahman Crescent Institute of Science and Technology, Department of Pharmaceutics Presented findings at the 2024 International Conference on Advanced Functional Materials and Devices. Artificial Intelligence-based Network Biology on Pancreatic Cancer KRAS Onco Gene Associate RALGDS Targeted Inhibitors Mentor: Dr. Irfan Navabshan. Institution: B. S. Abdur Rahman Crescent Institute of Science and Technology, Department of Pharmaceutical Chemistry Evaluated the efficacy of RALGDS inhibitors integrating AI in pancreatic cancer treatment
š Publications
- Several articles in peer-reviewed journals and book chapters, including “Nanomedicine facilitated cell signaling blockade” in Journal of Materials Chemistry B (IF: 7.5)
š Conferences & Webinars
- Participated in international conferences and webinars on translational research, scientific writing, pharmacovigilance, and more
š Honors & Awards
- Recognized at various academic and professional events, including World Pharmacist Day by Pfizer R&D and National Youth Parliament
š§ Workshop & Courses
Attended workshops on pharmacovigilance, in-silico modeling in drug development, AI for journal abstract matching, and more
š©āš« Experience
- Project assistant (Part-time) at D3 Drug Tech Limited, experienced in insilico work This summary highlights your academic achievements, research projects, skills, and professional engagements effectively.
Publication:š
Title: Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma
Authors: M Habeeb, HT Vengateswaran, HW You, K Saddhono, KB Aher, …
Journal: Journal of Materials Chemistry B
Year: 2024
Citations: 1